| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Pathology, Brigham and Womens Hospital, Boston, Massachusetts 02115 [M. K. H., P. D. C., X. T., S. X., J. A. F.]; Department of Pathology, Childrens Hospital, Boston, Massachusetts 02115 [H. P. K.]; Department of Pathology, University Hospital, B-3000 Leuven, Belgium [R. S.]; and Department of Pediatric-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 [J. A. F.]
Lipoblastomas are pediatric neoplasms resulting from transformation of
adipocytes. These benign tumors are typically composed of adipose cells
in different stages of maturation within a variably myxoid matrix, and
they contain clonal rearrangements of chromosome band 8q12. Because
lipoblastomas resemble embryonic adipose tissue, characterization of
their transforming mechanisms might reveal biological pathways in
physiological adipogenesis. Herein, we demonstrate that lipoblastoma
chromosome 8q12 rearrangements bring about promoter-swapping events in
the PLAG1 oncogene. We show that the hyaluronic acid
synthase 2 (HAS2) or collagen 1
2
(COL1A2) gene promoter regions are fused to the entire
PLAG1 coding sequence in each of four lipoblastomas.
PLAG1 is a developmentally regulated zinc finger gene
whose tumorigenic function has been shown previously only in epithelial
salivary gland cells. Our findings reveal that PLAG1
activation, presumably resulting from transcriptional up-regulation, is
a central oncogenic event in lipoblastoma.
This article has been cited by other articles:
![]() |
F. J. Kaye Mutation-associated fusion cancer genes in solid tumors Mol. Cancer Ther., June 1, 2009; 8(6): 1399 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pajer, V. Pecenka, J. Kralova, V. Karafiat, D. Prukova, Z. Zemanova, R. Kodet, and M. Dvorak Identification of Potential Human Oncogenes by Mapping the Common Viral Integration Sites in Avian Nephroblastoma Cancer Res., January 1, 2006; 66(1): 78 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zheng and Y.-C. Yang Sumoylation and Acetylation Play Opposite Roles in the Transactivation of PLAG1 and PLAGL2 J. Biol. Chem., December 9, 2005; 280(49): 40773 - 40781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Declercq, F. Van Dyck, C. V. Braem, I. C. Van Valckenborgh, M. Voz, M. Wassef, L. Schoonjans, B. Van Damme, L. Fiette, and W. J.M. Van de Ven Salivary Gland Tumors in Transgenic Mice with Targeted PLAG1 Proto-Oncogene Overexpression Cancer Res., June 1, 2005; 65(11): 4544 - 4553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Landrette, Y.-H. Kuo, K. Hensen, S. B. van Waalwijk van Doorn-Khosrovani, P. N. Perrat, W. J. M. Van de Ven, R. Delwel, and L. H. Castilla Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11 Blood, April 1, 2005; 105(7): 2900 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Oliveira, A. R. Perez-Atayde, C. Y. Inwards, F. Medeiros, V. Derr, B.-L. Hsi, M. C. Gebhardt, A. E. Rosenberg, and J. A. Fletcher USP6 and CDH11 Oncogenes Identify the Neoplastic Cell in Primary Aneurysmal Bone Cysts and Are Absent in So-Called Secondary Aneurysmal Bone Cysts Am. J. Pathol., November 1, 2004; 165(5): 1773 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Van Dyck, E. L. D. Delvaux, W. J. M. Van de Ven, and M. V. Chavez Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation J. Biol. Chem., August 20, 2004; 279(34): 36121 - 36131. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Jones, J. A. Morcuende, B. R. DeYoung, G. Y. El-Khoury, J. A. Buckwalter, and F. R. Dietz Unusual Presentation of Lipoblastoma as a Skin Dimple of the Thigh. A Report of Three Cases J. Bone Joint Surg. Am., May 1, 2004; 86(5): 1040 - 1046. [Full Text] [PDF] |
||||
![]() |
L. H. Castilla, P. Perrat, N. J. Martinez, S. F. Landrette, R. Keys, S. Oikemus, J. Flanegan, S. Heilman, L. Garrett, A. Dutra, et al. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia PNAS, April 6, 2004; 101(14): 4924 - 4929. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Oliveira, B.-L. Hsi, S. Weremowicz, A. E. Rosenberg, P. D. Cin, N. Joseph, J. A. Bridge, A. R. Perez-Atayde, and J. A. Fletcher USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst Cancer Res., March 15, 2004; 64(6): 1920 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chang and V. B. Shidham Molecular Genetics of Pediatric Soft Tissue Tumors: Clinical Application J. Mol. Diagn., August 1, 2003; 5(3): 143 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Kuiper, M. Schepens, J. Thijssen, M. van Asseldonk, E. van den Berg, J. Bridge, E. Schuuring, E. F.P.M. Schoenmakers, and A. G. van Kessel Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution Hum. Mol. Genet., July 15, 2003; 12(14): 1661 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hensen, I. C. C. Van Valckenborgh, K. Kas, W. J. M. Van de Ven, and M. L. Voz The Tumorigenic Diversity of the Three PLAG Family Members Is Associated with Different DNA Binding Capacities Cancer Res., March 1, 2002; 62(5): 1510 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gisselsson, M. K. Hibbard, P. Dal Cin, R. Sciot, B.-L. Hsi, H. P. Kozakewich, and J. A. Fletcher PLAG1 Alterations in Lipoblastoma : Involvement in Varied Mesenchymal Cell Types and Evidence for Alternative Oncogenic Mechanisms Am. J. Pathol., September 1, 2001; 159(3): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |